Extract from the Register of European Patents

EP About this file: EP4337947

EP4337947 - POINT-OF-USE SYSTEM AND METHOD FOR IDENTIFYING COMPONENTS OF AN UNKNOWN DRUG SAMPLE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  16.02.2024
Database last updated on 07.03.2026
FormerThe international publication has been made
Status updated on  29.11.2022
Most recent event   Tooltip15.09.2025The date on which the examining division becomes responsible, has been established 
15.09.2025Amendment by applicant 
Applicant(s)For all designated states
Unity Health Toronto
30 Bond Street
Toronto, Ontario M5B 1W8 / CA
For all designated states
The Regents of the University of California
1111 Franklin Street, 5th Floor
Oakland, CA 94607-5200 / US
[2024/12]
Inventor(s)01 / HALL, Drew
La Jolla, California 92037 / US
02 / WERB, Daniel
Toronto, Ontario M5B 1W8 / CA
03 / BERIAULT, Daniel
Toronto, Ontario M5B 1W8 / CA
 [2024/12]
Representative(s)Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2024/12]Murgitroyd & Company
165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date22806156.011.05.2022
[2024/12]
WO2022CA50737
Priority number, dateUS202163187875P12.05.2021         Original published format: US 202163187875 P
[2024/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022236411
Date:17.11.2022
Language:EN
[2022/46]
Type: A1 Application with search report 
No.:EP4337947
Date:20.03.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2022 takes the place of the publication of the European patent application.
[2024/12]
Search report(s)International search report - published on:CA17.11.2022
(Supplementary) European search report - dispatched on:EP19.02.2025
ClassificationIPC:G06Q30/018, G16C20/20, // A61B5/145, G01N33/487
[2025/12]
CPC:
G16C20/20 (EP); G16C20/70 (EP,US); G01N27/416 (US);
G01N33/94 (EP); G06Q30/0185 (EP); G06N20/00 (EP)
Former IPC [2024/12]G01N27/416
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/12]
TitleGerman:SYSTEM UND VERFAHREN ZUR IDENTIFIZIERUNG VON KOMPONENTEN EINER UNBEKANNTEN ARZNEIMITTELPROBE[2024/12]
English:POINT-OF-USE SYSTEM AND METHOD FOR IDENTIFYING COMPONENTS OF AN UNKNOWN DRUG SAMPLE[2024/12]
French:SYSTÈME ET PROCÉDÉ AU POINT D'UTILISATION POUR IDENTIFIER DES COMPOSANTS D'UN ÉCHANTILLON DE MÉDICAMENT INCONNU[2024/12]
Entry into regional phase13.11.2023National basic fee paid 
13.11.2023Search fee paid 
13.11.2023Designation fee(s) paid 
13.11.2023Examination fee paid 
Examination procedure13.11.2023Examination requested  [2024/12]
10.09.2025Amendment by applicant (claims and/or description)
10.09.2025Date on which the examining division has become responsible
Fees paidRenewal fee
17.05.2024Renewal fee patent year 03
26.05.2025Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY] WO2021012053  (UNIV BRITISH COLUMBIA et al.) [X] 1,3-11,14,15 * abstract * * figure - * * paragraphs [0001] , [0002] , [0009] , [0010] , [0080] , [0098] - [0103] - [0116] - [0129] - [0138] - [0142] *[Y] 2,12,13
 [Y] US2019197861  (TUNNELL DAVID et al.) [Y] 2,12,13 * paragraphs [0002] , [0017] , [0022] , [0100] *
 [X] US2021015431  (KANG BYEONG KEUN et al.) [X] 1,11 * abstract * * figures 1-4 * * paragraphs [0012] - [0014] - [0040] , [0045] , [0057] - [0060] - [0066] *
 [X]   AIASSA SIMONE ET AL: "Smart Portable Pen for Continuous Monitoring of Anaesthetics in Human Serum With Machine Learning", IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS, IEEE, US, vol. 15, no. 2, 19 March 2021 (2021-03-19), pages 294 - 302, XP011856752, ISSN: 1932-4545, [retrieved on 20210524], DOI: 10.1109/TBCAS.2021.3067388 [X] 1,11 * abstract * * figure 2 * * paragraph "II. THE SYSTEM" *

DOI:   http://dx.doi.org/10.1109/TBCAS.2021.3067388
 [A]   TEYMOURIAN HAZHIR ET AL: "Wearable Electrochemical Sensors for the Monitoring and Screening of Drugs", ACS SENSORS, 25 September 2020 (2020-09-25), United States, pages 2679 - 2700, XP055817948, Retrieved from the Internet [retrieved on 20210624], DOI: 10.1021/acssensors.0c01318 [A] 1-15 * page 10, lines 15-18 *

DOI:   http://dx.doi.org/10.1021/acssensors.0c01318
International search[[X, Y]] WO2021012053  (UNIV BRITISH COLUMBIA et al.) [[X, Y]] 1-26 *entire doc.; [0120], [0109], [0010], [0126], [0187], [0139], [0015], [0018], [0062], [0116-7] [0005], [0142], [0141]*
 [[X]] US8414846  (GOLD MARK S et al.) [[X]] 2-4 *abstract; col. 19, lines 8-19*
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.